Your browser doesn't support javascript.
loading
Methotrexate pharmacokinetic genetic variants are associated with outcome in rheumatoid arthritis patients.
Moya, Patricia; Salazar, Juliana; Arranz, María Jesús; Díaz-Torné, César; del Río, Elisabeth; Casademont, Jordi; Corominas, Hèctor; Baiget, Montserrat.
Affiliation
  • Moya P; Internal Medicine Department, Hospital de la Santa Creu i Sant Pau, Barcelona.
  • Salazar J; Faculty of Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona.
  • Arranz MJ; Genetics Department, Hospital de la Santa Creu i Sant Pau, Barcelona.
  • Díaz-Torné C; U705, ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Madrid.
  • del Río E; Fundació Docència i Recerca Mutua Terrassa, Terrassa.
  • Casademont J; Internal Medicine Department, Hospital de la Santa Creu i Sant Pau, Barcelona.
  • Corominas H; Genetics Department, Hospital de la Santa Creu i Sant Pau, Barcelona.
  • Baiget M; Internal Medicine Department, Hospital de la Santa Creu i Sant Pau, Barcelona.
Pharmacogenomics ; 17(1): 25-9, 2016.
Article in En | MEDLINE | ID: mdl-26652611

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Anti-Inflammatory Agents, Non-Steroidal / Methotrexate / Polymorphism, Single Nucleotide Type of study: Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Pharmacogenomics Journal subject: FARMACOLOGIA / GENETICA MEDICA Year: 2016 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Anti-Inflammatory Agents, Non-Steroidal / Methotrexate / Polymorphism, Single Nucleotide Type of study: Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Pharmacogenomics Journal subject: FARMACOLOGIA / GENETICA MEDICA Year: 2016 Document type: Article Country of publication: United kingdom